米国の除細動器市場規模、シェア、動向分析レポート：製品別、最終用途別、セグメント別予測、2024年～2030年

米国の除細動器市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の除細動器市場規模は2024年から2030年にかけてCAGR 7.3％を示し、2030年には43億2,000万米ドルに達すると予測されています。

技術の進歩の増加、突然の心停止やCVDの発生率の上昇、新興アプリケーションでの採用の増加、政府や医療機関による支援的イニシアチブは、業界の成長を促進する主な要因の一部です。

米国における心血管疾患の有病率の上昇は、米国除細動器市場の主要な推進力となっています。例えば、米国疾病予防管理センター（CDC）によると、米国では年間約454,000件の入院で心房細動（AFib）が主な診断となっています。この健康状態は年間約158,000人の死亡に寄与しています。このような心血管疾患の動向の高まりは、予測期間中の市場成長に寄与すると予想されます。

老人人口の増加と技術の進歩は、市場成長に大きな影響を与えると予想されます。65歳以上の高齢者は、心血管疾患（CVD）などの慢性疾患にかかりやすい傾向が強いです。例えば、「高齢者人口統計」と題された2022年11月の記事：A Portrait of Aging Americans（高齢化する米国人の肖像）」によると、米国では約5,410万人（16.3％）が65歳以上であることが明らかになった。その結果、老人人口の増加がこれらの製品に対する需要を牽引しています。

米国除細動器市場レポート・ハイライト

• 植込み型除細動器（ICD）が2023年に50%以上のシェアを占め、市場を独占しました。このセグメントの成長を促進する主な要因には、CVDの高い有病率、主要市場における高齢者人口の多さ、製品アプリケーションの拡大と技術進歩によるこれらのデバイスの採用の増加が含まれます。
• 2023年には、病院での心臓疾患の症例数が多く、手術も病院で行われるため、病院分野が最大の売上シェアを占めました。
• 2024年から2030年にかけてのCAGRは、パブリックアクセスAEDの利用可能性を高めるためのイニシアチブの高まりにより、パブリックアクセス市場セグメントが最も速くなると予測されています。
• 米国の除細動器市場で事業を展開する市場プレーヤーには、メドトロニック、アボット、ボストン・サイエンティフィック・コーポレーション、BIOTRONIK SE &Co.KG、MicroPort Scientific Corporation、Koninklijke Philips N.V.、Stryker、ZOLL Medical Corporation（旭化成）、日本光電工業株式会社、Siemens Healthineersなどです。
• 2024年2月、植込み型医療機器の分野で著名なBIOTRONIK社は、将来のシングルチャンバーICD植込みに同社の革新的なDXモデルを独占的に提供することを決定したと発表しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の除細動器市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 米国除細動器市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の除細動器市場：製品の推定・動向分析

• 製品市場シェア、2023年および2030年
• セグメントダッシュボード
• 米国の除細動器市場：製品別展望
• 2018年から2030年までの市場規模と予測およびトレンド分析

第5章 米国の除細動器市場：最終用途の推定・動向分析

• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 最終用途別米国除細動器市場展望
• 2018年から2030年までの市場規模と予測およびトレンド分析

第6章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company heat map analysis, 2023年
• 企業プロファイル
  • Medtronic
  • Koninklijke Philips NV
  • Siemens Healthineers
  • Abbott
  • Boston Scientific Corporation
  • BIOTRONIK SE &Co. KG
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Stryker

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. defibrillators market, by product, 2018 - 2030 (USD Million)
• Table 3 U.S. defibrillators market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. defibrillators market: Market outlook
• Fig. 9 U.S. defibrillators competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 U.S. defibrillators market driver impact
• Fig. 14 U.S. defibrillators market restraint impact
• Fig. 15 U.S. defibrillators market: Product movement analysis
• Fig. 16 U.S. defibrillators market: Product outlook and key takeaways
• Fig. 17 Implantable cardioverter defibrillators market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 S-ICD market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 T-ICD market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Single chamber market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Dual chamber market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 CRT-D market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 External defibrillators estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Manual ED market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Automated ED market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Wearable cardioverter defribrillators market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 U.S. defibrillators market: End-Use movement analysis
• Fig. 28 U.S. defibrillators market: End use outlook and key takeaways
• Fig. 29 Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Pre-hospital market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 31 Public access market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 32 Alternate care market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 33 Home healthcare market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 34 Market share of key market players - U.S. defibrillators market

U.S. Defibrillator Market Growth & Trends:

The U.S. defibrillator market size is anticipated to reach USD 4.32 billion by 2030, exhibiting a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing technological advancements, rising incidence of sudden cardiac arrest and CVD's, rising adoption in emerging applications, and supportive initiatives by governments & healthcare organizations are some of the key factors fueling industry growth.

The escalating prevalence of cardiovascular diseases in the U.S. serves as a major driving force for the U.S. defibrillator market. For instance, as per the Centers for Disease Control and Prevention (CDC), around 454,000 hospitalizations annually in the U.S. involve Atrial Fibrillation (AFib) as the primary diagnosis. This health condition contributes to around 158,000 annual deaths. This rising trend of cardiovascular diseases is expected to contribute to market growth during the forecast period.

The rising geriatric population and technological advancements are expected to significantly impact market growth. Individuals aged 65 years and above are highly prone to chronic illnesses such as cardiovascular diseases (CVDs). For instance, a November 2022 article titled "Senior Population Statistics: A Portrait of Aging Americans" revealed that approximately 54.1 million (16.3%) people in the U.S. are 65 years or older. Consequently, the growing geriatric population drives the demand for these products.

U.S. Defibrillator Market Report Highlights:

• Implantable cardioverter defibrillators (ICDs) dominated the market with a share of more than 50% in 2023. Key factors driving this segment growth include the rising adoption of these devices due to the high prevalence of CVDs, the high geriatric population in key markets, and growing product applications and technological advancement.
• Hospital segment held the largest revenue share in 2023 owing to the higher volume of cardiac cases in hospitals and surgeries performed in hospital settings.
• The public access market segment is anticipated to register the fastest CAGR from 2024 to 2030 due to the rising initiatives to increase the availability of public access AEDs.
• Market players operating in the U.S. defibrillator market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Koninklijke Philips N.V., Stryker, ZOLL Medical Corporation (Asahi Kasei), Nihon Kohden Corporation, and Siemens Healthineers.
• In February 2024, BIOTRONIK, a prominent company in the field of implantable medical devices, declared its decision to exclusively provide their innovative DX models for future single-chamber ICD implantations.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End-Use
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End-Use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Defibrillator Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing technological advancements
    • 3.2.1.2. Rising incidence of sudden cardiac arrest and CVD's
    • 3.2.1.3. Supportive initiatives by governments & healthcare organizations
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations & approvals
• 3.3. U.S. Defibrillator Market Analysis Tools
  • 3.2.3. Industry Analysis - Porter's
    • 3.2.3.1. Supplier power
    • 3.2.3.2. Buyer power
    • 3.2.3.3. Substitution threat
    • 3.2.3.4. Threat of new entrant
    • 3.2.3.5. Competitive rivalry
  • 3.2.4. PESTEL Analysis
    • 3.2.3.1. Political landscape
    • 3.2.3.2. Technological landscape
    • 3.2.3.3. Economic landscape

Chapter 4. U.S. Defibrillator Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Defibrillator Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Implantable cardioverter defibrillators (ICD)
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. S-ICD
    • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. T-ICD
    • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3.2. Single chamber
    • 4.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3.3. Dual chanmber
    • 4.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3.4. CRT-D
    • 4.4.1.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. External defibrillators
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Manual ED
    • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Automated ED
    • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.4. Wearable cardoverter defribrillators
    • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Defibrillator Market: End-Use Estimates & Trend Analysis

• 5.1. End-Use Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Defibrillator Market by End-Use Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Hospital
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Pre-hospital
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Public access market
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Alternate care market
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Home healthcare
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company heat map analysis, 2023
• 6.4. Company Profiles
  • 6.4.1. Medtronic
    • 6.4.1.1. Company overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Koninklijke Philips N.V.
    • 6.4.2.1. Company overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. Siemens Healthineers
    • 6.4.3.1. Company overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. Abbott
    • 6.4.4.1. Company overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Boston Scientific Corporation
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. BIOTRONIK SE & Co. KG
    • 6.4.6.1. Company overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. MicroPort Scientific Corporation
    • 6.4.7.1. Company overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Nihon Kohden Corporation
    • 6.4.8.1. Company overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. Stryker
    • 6.4.9.1. Company overview
    • 6.4.9.2. Financial performance
    • 6.4.9.3. Product benchmarking
    • 6.4.9.4. Strategic initiatives